In Florida overlooking the Intercoastal Waterway..
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I wish you the best in what ever life has in store for you.. Get healthy and go catch that brass ring.. Life seems to be the best when we overcome obsticles that we never thought about and when we least expect them.. It's usually health and when that is realized living one day at a time doing things that you only dreamed about,, will extend not only your value of life but life itself.. Best of luck to you in the future,, hank
Those new orders PR'ed recently if true they were probably the same orders as those that they had in the backlog that/which included in a if come bet of unsigned orders but,, were included as backlog..
As to what happened to the petting ZOO.. It would not be a surprise if it was bought by Ron on a note that will be redeemed for bonus shares.. hank
SMELL TEST: https://encrypted-tbn3.gstatic.com/images?q=tbn:ANd9GcSzYU_JqvH3V351v7hd-Nuodj0PciebqhkWCdDvczH1X6Y1ulbM
As to YORK,, It was so discusted with DDI that they didn't even discuss with DDI the sale.. Although the sale caused a loss I asked Gene in a CC why they still took a bonus after the disaster.. His answer basicly was because they could..
--------------------------------------------------------
They bought Flotec and the sellers would not accept a share of DPDW as payment.. In fact shareholders were told that it was accretive and was to fit right in with another division of the company that was in the same business..
Those if true were prob. the me as those the thought they had in the backlog that included prob, but unsigned orders.. As to the petting ZOO.. It was Prob bought by Ron on a note that will be redeemed for bonus shares.. hank
SMELL TEST: https://encrypted-tbn3.gstatic.com/images?q=tbn:ANd9GcSzYU_JqvH3V351v7hd-Nuodj0PciebqhkWCdDvczH1X6Y1ulbM
"Wow U bought this @ .12 and were told no dilution "
That is not what I posted.. I only paid $0.015 and between the release I used for DD and the next release they diluted 50%.. I sold on a P&D around $0.02,, but it traded as high at $0.043 that day and closed down on the day @$0.018.. Funny the trading for the day was almost the reported float but on the next report the shares had doubled again.. It appears that even though most loan holders may only own 9.9% they may convert each time they sell as long as they do not exceed 9.9%..
The new preferred h holders have no restriction as to how many they convert and they are about to come up to their holding period.. So the lower the can get ACGX before they convert at a 30% discount to the market the more shares they get..
Sure it's a nice little company,, almost the same as it was when it earned $0.12 per share.. If it wasn't do you really think a company with a few copying machines could extract money from over 650 Million shares just by telling people that they are just trying to conserve cash when they could of paid it off years ago.. And why did they need the money from the New Preferred last year except to extract more funds..??
Last night there was a 50 million show bid @$0.0012.. But it was just for show.. hank
You are correct and I agree with you that ACGX is not a POT stock.. Any reference to it is/has been removed from the I-Box info.. But don't think I post to stir things up because I only answer half of the barbs thrown my way..
Good luck to you in your investment but since I owned it when it earned $0.12 per share and was told not to worry about dilution when there were but 8.5 million shares outstanding I learned the hard way about dilution.. It destroys shareholder value but has no effect to those that control thru the preferred.. They as here just increase their rate of conversion to suit their own selfishness and control.... hank
This is a fact.. There are no bids and a increase in auth. shares is coming soon.. Listen to the Conference call.. That was also a joke because they only spoke to themselves and the questions they made up..
I know of 10 that were posted here that were not discussed..
NO WAY,, THE COMPANY IS THE JOKE..
And this was just 2 years ago.. The time has sure flew by fast but,, I doubt if we will ever see these day's again.. hank
10 bagger Member Level Saturday, 04/13/13 08:11:38 PM
Re: None
Post # of 385
Market Value Top 20 Trading Positions... A lot tougher week than it looks as there was a "painter" in a couple of the stocks.. HLMB made a round trip on record volume,, HIIT was added ,, DTRK was bought/added to in size and CIBH retreated.. Boll and PAOS are the falling stars so far this month.. hank
RESULTS,, Week 2.... 4/12/13 Second week of April..
Market Value Top 20 Trading Positions: $1,522,192.43 (+$91,607.74 / + 6.40%) Since 03/28/2013 and ( +42.62%) Since Year End 2012..
April Starting position.. $1,420,960.90 Up 36.22% since YE..
04/12/13 3:57 PM EDT Sell 250 DTRK Executed @ $0.6488 Details | Edit now $5.99
04/12/13 3:56 PM EDT Buy 5000 HIIT Executed @ $0.2108 Details | Edit
04/12/13 3:49 PM EDT Sell 609 HIIT Executed @ $0.2275 Details | Edit
04/12/13 3:44 PM EDT Sell 1000 HIIT Executed @ $0.2275 Details | Edit
04/12/13 3:40 PM EDT Buy 10000 GLMB Executed @ $0.1125 Details | Edit
04/12/13 3:19 PM EDT Sell 100 DTRK Executed @ $0.6488 Details | Edit
04/12/13 2:47 PM EDT Buy 1600 DTRK Executed @ $0.61 Details | Edit
04/12/13 2:00 PM EDT Buy 3400 DTRK Executed @ $0.61 Details | Edit
04/12/13 1:47 PM EDT Buy 100 HIIT Executed @ $0.2108 Details | Edit
04/12/13 1:29 PM EDT Buy 16000 KLYG Executed @ $0.0758 Details | Edit
04/12/13 1:19 PM EDT Sell 2600 HIIT Executed @ $0.2275 Details | Edit
04/12/13 1:03 PM EDT Buy 7600 HIIT Executed @ $0.2108 Details | Edit
04/12/13 12:55 PM EDT Buy 28888 GLMB Executed @ $0.1128 Details | Edit
04/12/13 12:44 PM EDT Buy 18888 GLMB Executed @ $0.1168 Details | Edit
04/12/13 12:19 PM EDT Buy 21700 DTRK Executed @ $0.6 Details | Edit
04/12/13 12:19 PM EDT Buy 621 DTRK Executed @ $0.6 Details | Edit
04/12/13 12:19 PM EDT Buy 900 DTRK Executed @ $0.6 Details | Edit
04/12/13 12:19 PM EDT Buy 1500 DTRK Executed @ $0.6 Details | Edit
04/12/13 12:16 PM EDT Buy 900 HIIT Executed @ $0.2108 Details | Edit
04/12/13 12:01 PM EDT Buy 2400 HIIT Executed @ $0.22 Details | Edit
04/12/13 12:01 PM EDT Buy 25000 HIIT Executed @ $0.22 Details | Edit
04/12/13 12:01 PM EDT Buy 2500 HIIT Executed @ $0.22 Details | Edit
04/12/13 12:01 PM EDT Buy 5000 HIIT Executed @ $0.22 Details | Edit
04/12/13 11:38 AM EDT Buy 2500 HIIT Executed @ $0.21 Details | Edit
04/12/13 11:20 AM EDT Buy 4100 KLYG Executed @ $0.0788 Details | Edit
04/12/13 10:49 AM EDT Buy 18888 GLMB Executed @ $0.1208 Details | Edit
04/12/13 10:43 AM EDT Buy 719 DTRK Executed @ $0.5428 Details | Edit
04/12/13 9:37 AM EDT Buy 10100 KLYG Executed @ $0.08 Details | Edit
04/12/13 9:37 AM EDT Buy 9900 KLYG Executed @ $0.079 Details | Edit
04/11/13 4:23 PM EDT Buy 2500 KLYG Executed @ $0.0638 Details | Edit
04/11/13 3:06 PM EDT Buy 8888 HIIT Executed @ $0.2 Details | Edit
04/11/13 2:38 PM EDT Buy 17000 HIIT Executed @ $0.2 Details | Edit
04/11/13 2:34 PM EDT Buy 750 ENSV Executed @ $1.25 Details | Edit
04/11/13 2:15 PM EDT Buy 18888 HIIT Executed @ $0.2 Details | Edit
04/11/13 2:08 PM EDT Sell 7712 GLMB Executed @ $0.13 Details | Edit
04/11/13 2:06 PM EDT Buy 17000 DTRK Executed @ $0.59 Details | Edit
04/11/13 1:46 PM EDT Buy 800 ENSV Executed @ $1.25 Details | Edit
04/11/13 1:38 PM EDT Buy 6000 KLYG Executed @ $0.0808 Details | Edit
04/11/13 11:42 AM EDT Buy 300 GAMR Executed @ $0.49 Details | Edit
04/11/13 10:47 AM EDT Buy 2400 ENSV Executed @ $1.25 Details | Edit
04/11/13 9:30 AM EDT Sell 7500 VSTI Executed @ $0.19 Details | Edit
04/10/13 3:18 PM EDT Buy 34615 HIIT Executed @ $0.1965 Details | Edit
04/10/13 2:26 PM EDT Sell 32612 CONX Executed @ $0.2288 Details | Edit
04/10/13 12:47 PM EDT Sell 2000 CONX Executed @ $0.2288 Details | Edit
Details | Edit
04/10/13 11:19 AM EDT Buy 1000 DTRK Executed @ $0.5118 Details | Edit
04/10/13 10:51 AM EDT Buy 18888 GLMB Executed @ $0.1308 Details | Edit
04/10/13 10:25 AM EDT Buy 10000 GLMB Executed @ $0.1308 Details | Edit
04/10/13 10:22 AM EDT Buy 6400 GLMB Executed @ $0.1308 Details | Edit
04/10/13 10:10 AM EDT Buy 25000 GLMB Executed @ $0.131 Details | Edit
04/10/13 10:10 AM EDT Buy 18970 GLMB Executed @ $0.131 Details | Edit
04/10/13 9:50 AM EDT Buy 1112 GLMB Executed @ $0.134 Details | Edit
04/10/13 9:50 AM EDT Buy 7388 GLMB Executed @ $0.134 Details | Edit
04/10/13 9:33 AM EDT Sell 8000 DTRK Executed @ $0.58 Details | Edit
04/10/13 9:30 AM EDT Sell 1591 DTRK Executed @ $0.5988 Details | Edit
04/09/13 3:55 PM EDT Sell 7500 GLMB Executed @ $0.139 Details | Edit
04/09/13 3:51 PM EDT Buy 38888 GLMB Executed @ $0.1328 Details | Edit
04/09/13 3:14 PM EDT Sell 200 ASNB Executed @ $0.075 Details | Edit
04/09/13 2:48 PM EDT Sell 348 PYDS Executed @ $0.111 Details | Edit
04/09/13 2:12 PM EDT Sell 3739 ASNB Executed @ $0.075 Details | Edit
04/09/13 2:05 PM EDT Sell 10000 GLMB Executed @ $0.151 Details | Edit
04/09/13 1:47 PM EDT Sell 7000 CONX Executed @ $0.2288 Details | Edit
04/09/13 12:24 PM EDT Sell 3900 GLMB Executed @ $0.1465 Details | Edit
04/09/13 11:59 AM EDT Sell 15000 GLMB Executed @ $0.14 Details | Edit
04/09/13 11:59 AM EDT Sell 13100 GLMB Executed @ $0.1465 Details | Edit
04/09/13 11:20 AM EDT Sell 17900 GLMB Executed @ $0.139 Details | Edit
04/09/13 11:14 AM EDT Sell 100 GLMB Executed @ $0.139 Details | Edit
04/09/13 11:08 AM EDT Buy 3088 GLMB Executed @ $0.1328 Details | Edit
04/09/13 11:08 AM EDT Buy 19800 GLMB Executed @ $0.1328 Details | Edit
04/09/13 10:49 AM EDT Sell 2400 GLMB Executed @ $0.149 Details | Edit
04/09/13 10:49 AM EDT Sell 5000 GLMB Executed @ $0.149 Details | Edit
04/09/13 10:48 AM EDT Sell 39443 GLMB Executed @ $0.149 Details | Edit
04/09/13 10:48 AM EDT Sell 5000 GLMB Executed @ $0.149 Details | Edit
04/09/13 10:48 AM EDT Sell 4215 GLMB Executed @ $0.15 Details | Edit
04/09/13 10:47 AM EDT Sell 30000 GLMB Executed @ $0.149 Details | Edit
04/09/13 10:46 AM EDT Sell 10000 GLMB Executed @ $0.14 Details | Edit
04/09/13 10:43 AM EDT Sell 4100 GLMB Executed @ $0.14 Details | Edit
04/09/13 10:43 AM EDT Sell 5000 GLMB Executed @ $0.14 Details | Edit
04/09/13 10:43 AM EDT Sell 20000 GLMB Executed @ $0.14 Details | Edit
04/09/13 10:35 AM EDT Sell 5000 GLMB Executed @ $0.15 Details | Edit
04/09/13 10:33 AM EDT Sell 6588 GLMB Executed @ $0.14 Details | Edit
04/09/13 10:33 AM EDT Sell 15000 GLMB Executed @ $0.14 Details | Edit
04/09/13 10:33 AM EDT Sell 4000 GLMB Executed @ $0.136 Details | Edit
04/09/13 10:33 AM EDT Sell 5000 GLMB Executed @ $0.136 Details | Edit
04/09/13 10:33 AM EDT Sell 5000 GLMB Executed @ $0.136 Details | Edit
04/09/13 10:33 AM EDT Sell 8228 GLMB Executed @ $0.135 Details | Edit
04/09/13 10:32 AM EDT Sell 7000 GLMB Executed @ $0.135 Details | Edit
04/09/13 10:32 AM EDT Sell 15737 GLMB Executed @ $0.132 Details | Edit
04/09/13 9:56 AM EDT Buy 24888 TEXC Executed @ $0.1108 Details | Edit
04/09/13 9:56 AM EDT Buy 4000 TEXC Executed @ $0.1108 Details | Edit
04/09/13 9:30 AM EDT Sell 2554 PYDS Executed @ $0.1198 Details | Edit
04/08/13 3:59 PM EDT Sell 20000 PYDS Executed @ $0.1198 Details | Edit
04/08/13 3:49 PM EDT Sell 1000 PYDS Executed @ $0.1198 Details | Edit
04/08/13 2:10 PM EDT Sell 507 SPND Executed @ $3.98 Details | Edit
04/08/13 2:10 PM EDT Sell 550 SPND Executed @ $3.98 Details | Edit
04/08/13 1:41 AM EDT Sell 8000 SPND Executed @ $3.95 Details | Edit
04/08/13 1:07 PM EDT Sell 3000 ASNB Executed @ $0.078 Details | Edit
04/08/13 12:14 PM EDT Sell 100 APNX Executed @ $0.1288 Details | Edit
04/08/13 11:43 AM EDT Sell 655 SPND Executed @ $3.7 Details | Edit
04/08/13 11:40 AM EDT Sell 1950 SPND Executed @ $3.7 Details | Edit
04/08/13 11:40 AM EDT Sell 50 SPND Executed @ $3.7 Details | Edit
04/08/13 11:36 AM EDT Sell 300 SPND Executed @ $3.7 Details | Edit
04/08/13 11:36 AM EDT Sell 600 SPND Executed @ $3.7 Details | Edit
Facts = Bashing..??? OK how is this?? ACGX has had 0ver 100 enquires on their new ACGX Tank (like Shark Tank) and is looking to raise $5,000,000 to fund some of them..
They also said that it was patent pending.. Any one ever see an application..??
"The willingness to make initiatives in the kids safe packaging for CBD is a huge statement for a company to make and pursue "
I guess we need another link to this post..??
Do you have a link to this statement..??
If you say it enough times,, it must be true.. hank
According to many, many post's made NITE will make a bundle.. Good for NITE in figuring this joke of stock..
KLYG.. $0.075.. We all have our own cross to carry and I guess KLYG is mine.. I'll be up there the second week of May and see what's really up.. The PR guy was taken off retainer and like you and I we all have not a clue.. I'm still confident that I'm right and this will trade above $0.50 this year but most likely on a take over.. hank
Wait for $0.0006 after the preferred are converted and then the pump will come..hank
VSTI..??? Any news that has caused the sell off..???
New Application Instantly Calculates Relationship between Improved Service Delivery and Cost TAMPA, Fla., April 6, 2015 /PRNewswire/ -- Jagged Peak, Inc. (OTC BB: JGPK), a leading provider of enterprise-class eCommerce solutions and fulfillment services, will demonstrate its newest tool, Slick(TM) at the Home Delivery show this week in Atlanta, GA. Jagged Peak developed Slick, a service level improvement cost calculator, to help companies analyze the correlation between shipping costs, delivery time and service improvement. "Most companies we engage with want to improve the level of service they are providing their customers," says Dan Furlong, COO of Jagged Peak. "The challenge has always been providing them with an instant assessment of the cost impact to improve service levels across various scenarios. With Slick we can instantly calculate and display to our clients the total and average cost per order to upgrade a given percentage of orders from 2 day to next day delivery, as an example." "Transportation accounts for the greatest portion of fulfillment costs," said Michael Mercier, President of Jagged Peak. "Slick(TM) provides us and our clients with instant, accurate information to make intelligent business decisions that define how to best invest freight spend and achieve the maximum return. That's significant and provides us with a real competitive advantage in the marketplace." Slick(TM) represents the latest technology tool added to Jagged Peak's growing arsenal of information technologies designed to help companies optimize their order fulfillment programs. Jagged Peak's FlexNet(TM) fulfillment network is a multi-distribution center solution now comprised of 25 fulfillment locations across the U.S. and Canada. In September of 2014, Jagged Peak added Europe to the markets served with a fulfillment provider in North Hampton, UK. In Q4 of 2015, the company plans to offer APAC fulfillment capabilities through a strategic partnership with a Singapore based Logistics Company. "Last year, approximately 92% of our customer orders were delivered next day utilizing ground service. By 2016, we plan to deliver more than 50% of eCommerce orders, same day. Its tools and services like Slick(TM) and FlexNet(TM) that will help us achieve this high value fulfillment solution," said Vince Fabrizzi, Chief Sales and Marketing Officer of Jagged Peak. About Jagged Peak Jagged Peak is an eCommerce solutions provider with software and services that enhance the scalability, flexibility and profitability of omnichannel businesses. Its full-featured eCommerce Platform (ECP) and robust Order Management System (OMS) can be deployed alone or with a Warehouse Management System (WMS) and Transportation Management System (TMS) to form a shop-to-ship, web-based software suite that integrates the entire order life cycle with visibility across business units, distribution channels and trading partners. Media Contact: Kristine Bowman Director of Marketing Jagged Peak kbowman@jaggedpeak.com Photo - http://photos.prnewswire.com/prnh/20150403/196552 To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/jagged-peak-unveils-slick-at-home-delivery-show-300061011.html SOURCE Jagged Peak, Inc. /Web site: http://www.jaggedpeak.com (END) Dow Jones Newswires
GRC.V,, Any US symbol..?? hank
ACGX is the same company,, just name changed to get the new suckers aboard.. Looking back before the name change and DD will open some eyes..
Soon the Preferred will be able to convert w/o any restrictions as to how many.. 400,000,000 plus.. hank
OT.. Which penny stock is this..?? I'll give the Ans. later..
December 31,
2014
(unaudited) June 30,
2014
ASSETS
Current assets:
Cash and cash equivalents $ 589,492 $ 592,501
Accounts receivable, net 1,069,059 615,744
Inventories, net 1,386,457 1,371,832
Prepaid expenses 86,557 97,558
Total current assets 3,131,565 2,677,635
Equipment and leasehold improvements, net 557,807 630,217
Other assets 2,996 2,996
Total assets $ 3,692,368 $ 3,310,848
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable $ 1,936,174 $ 1,651,152
Accrued compensation 296,171 213,444
Accrued expenses and interest 145,407 216,386
Line of credit 815,525 698,258
Current portion of term note payable - shareholder 98,084 —
Unsecured lines of credit — 1,002
Current portion of leases payable 41,252 31,836
Current portion of deferred rent payable 11,091 81,263
Merchant cash advance (net of discount) 119,174 365,542
Short-term unsecured notes payable 685,297 988,464
Notes payable - related party 116,000 116,000
Total current liabilities 4,264,175 4,363,347
Long-term liabilities:
Leases payable 80,560 70,668
Deferred rent payable 225,750 44,290
Unsecured note payable 300,000 100,000
Term note payable - shareholder 578,892 —
Convertible notes payable - shareholder — 625,000
Total liabilities 5,449,377 5,203,305
Commitments and contingencies (note 13) — —
Stockholders’ deficit:
Preferred stock, 5,700,000 shares authorized, $0.0001 par value none issued and outstanding — —
Series A Convertible Preferred stock, 4,300,000 shares authorized $0.0001 par value, 4,300,000 shares issued and outstanding with a liquidation preference of $1,000,000 as of December 31, 2014 and June 30, 2014 430 430
Common stock of $0.01 par value, 175,000,000 shares authorized; 70,702,596 shares issued and outstanding at December 31, 2014 and at June 30, 2014 707,026 707,026
Additional paid-in capital 5,845,974 5,823,828
Accumulated deficit (8,310,439 ) (8,423,741 )
Total stockholders’ deficit (1,757,009 ) (1,892,457 )
Total liabilities and stockholders’ deficit $ 3,692,368 $ 3,310,848
Three Months Ended
December 31, Six Months Ended
December 31,
2014 2013 2014 2013
Net Sales $ 4,299,916 $ 4,217,534 $ 7,875,263 $ 7,490,228
Cost of goods sold 3,048,096 3,035,481 5,712,240 5,314,329
Gross profit 1,251,820 1,182,053 2,163,023 2,175,899
Operating expenses
Advertising and promotion 118,909 126,800 208,572 212,627
Other selling and marketing 302,727 324,109 615,726 663,682
General and administrative 464,301 487,491 912,748 917,357
Depreciation and amortization 58,804 57,121 113,935 114,970
Total operating expenses 944,741 995,521 1,850,981 1,908,636
Income from operations 307,079 186,532 312,042 267,263
Other Income (Expense):
Interest income 96 50 237 112
Interest (expense) and financing costs (109,550 ) (91,470 ) (198,977 ) (199,205 )
Total Other (Expense) (109,454 ) (91,420 ) (198,740 ) (199,093 )
Income before income taxes 197,625 95,112 113,302 68,170
Provision for income taxes — — — —
Net income $ 197,625 $ 95,112 $ 113,302 $ 68,170
Net income per share
Basic $ 0.00 $ 0.00 $ 0.00 $ 0.00
Diluted $ 0.00 $ 0.00 $ 0.00 $ 0.00
Shares used in computing net income per share
Basic 70,702,596 70,702,596 70,702,596 70,702,596
Diluted 70,702,596 70,702,596 70,702,596 70,702,596
See accompanying notes to unaudited interim financial statements.
Since this is April Fools day the following is I repeted for today.. This is a JOKE..
MTSL $1.62.. - Mer Telemanagement Solutions Ltd. (Nasdaq Capital Market: MTSL), a global provider of mobile virtual network enabler, mobile money and telecommunications expense management solutions and services, today announced that the shareholders of Mer Telemanagement Solutions Ltd. ("MTS") at an extraordinary general meeting of shareholders overwhelmingly approved the acquisition of Vexigo Ltd. ("Vexigo"), a privately-held Israeli-based software company supporting video advertising over the internet and mobile devices. Subsequent to the shareholder vote, the closing of the transaction was completed. Under the terms of the agreement, MTS acquired 100% of the outstanding shares of Vexigo in consideration of the payment of $3 million at closing and two future payments of $500,000 each. In addition, at closing MTS issued 40% of its ordinary shares post-closing to Vexigo's shareholders. The agreement further provides for earnout payments of up to $16 million over a 5.5 years period from the closing date, based on the earnings of the Vexigo product line. Vexigo will now operate as a wholly-owned subsidiary of MTS and its results will be consolidated in the financial statements of MTS as of April 1, 2015. In connection with the closing of the transaction, Mr. Isaac Ben-Bassat resigned as a member of our board of directors and Mr. Tzvika Friedman and Mr. Adi Orzel were appointed as members of our board of directors. "We are excited about this acquisition, which we believe will benefit our customers, partners, employees and shareholders," said Lior Salansky, CEO of MTS. "With this acquisition, we believe that we will have the scale and resources to expand our market position." "This transaction is in line with our business objectives and it is an important step in carrying out our strategy to enhance our business and increase shareholder value by making accretive acquisitions and entering into new business areas," said Mr. Chaim Mer, Chairman of the Board of the Company. "We welcome Tzvika Friedman and Adi Orzel to our board of directors," added Mr. Mer. MTS further announced today all of the proposed resolutions were adopted and approved by the required majority at the extraordinary general meeting of its shareholders held on April 1, 2015. For more information, please see the Notice and Proxy Statement relating to the 2015 extraordinary general meeting of shareholders furnished on Form 6-K to the Securities and Exchange Commission on February 18, 2015. About MTS Mer Telemanagement Solutions Ltd. (MTS) is a global provider of innovative products and services for telecom expense management (TEM), enterprise mobility management (EMM), mobile virtual network operators and enablers (MVNO/MVNE), billing mobile money services and solutions and an IOT/M2M enablement platform used by mobile service providers. The MTS TEM Suite solution enables enterprises to gain visibility and control of strategic fixed and mobile telecom assets, services and IT security policies that drive key business processes and provides a crucial competitive advantage. The MTS cloud, consulting and managed services solutions - including integrated management of invoices, assets, wireless, optimization, usage, mobile device management, procurement, help desk and bill payment, along with dashboards and reporting tools - provide professionals at every level of an organization with rapid access to concise, actionable data. The MTS solution for M2M (Machine to Machine) and Internet of Things (IoT) service providers is a comprehensive, proven and highly scalable cloud-based IoT enablement platform. The platform supports all business, operational, management and analytics services, features and functionality requirements of M2M and IoT service providers. MTS's solutions for wireless and wireline telecommunication service providers are used for interconnect billing, partner revenue management and for charging and invoicing services. The MTS MVNE services enable the quick launch of new MVNO initiatives in pay as you grow and revenue share models. In addition, MTS has pre-configured, full-features and scalable solutions to support emerging carriers of focused solutions (e.g. IPTV, VoIP, WiMAX, MVNO). Headquartered in Israel, MTS markets its solutions through wholly owned subsidiaries in the United States and Hong Kong and through distribution channels. MTS shares are traded on the NASDAQ Capital Market (symbol MTSL). For more information please visit the MTS web site: http://www.mtsint.com. Certain matters discussed in this news release are forward-looking statements that involve a number of risks and uncertainties including, but not limited to, risks in product development plans and schedules, rapid technological change, changes and delays in product approval and introduction, customer acceptance of new products, the impact of competitive products and pricing, market acceptance, the lengthy sales cycle, proprietary rights of the Company and its competitors, risk of operations in Israel, government regulations, dependence on third parties to manufacture products, general economic conditions and other risk factors detailed in the Company's filings with the United States Securities and Exchange Commission Company Contact: Alon Mualem CFO Tel: +972-9-7777-540 Email: Alon.Mualem@mtsint.com SOURCE MTS - Mer Telemanagement Solutions Ltd.
ACGX.. $0.0012..
I've always thought that a "thinking" discussion on a stock like ACGX is valuable. Post info gleaned from the SEC filings or other sources and make a statement or three about it.
State why you think it's the best thing since sliced bread or the worst stock ever.
That's what stock boards are for, I think.
I've posted a long time on this board and have held a substantial amount of shares at times. Not that it matters, and it shouldn't.
I think it would be hard to find individuals who have met or exceeded the amount of factual data that I have put forth on this or any stock. I'm certain there are some, but the number is few.
To that, I'll add that I have always made an effort to post correct data, as accuracy is always my goal. My opinions, when given, are honest. I've never pumped to sell high or bashed to buy cheap. In fact, I have been openly critical of some blunders made by ACGX at a time when I had sell offers in place.
So a question was posed with a preface that sounded like "hey I've followed this board for a long time and I'm amazed by your awesome DD" (I paraphrased it) followed by "but now that you're so negative I wish you would go away since you don't own shares and I don't think you will ever buy any. I think ACGX is great and I believe in it and it's management leadership. I want to buy more and believe in where ACGX is going"
In short my response is, I'll probably post on ACGX as long as I'm interested in doing so and still living. I have no time estimate on either at this point in time.
I'm not knowingly posting false information, if any errors can be pointed out I'll be happy to correct them and/or make updates as facts change. In that light, if anyone believes that ACGX will go higher in the future, the current prices should be viewed as an opportunity to buy low.
If sharing my recent opinions of ACGX management and ACGX share value on this board have in any way influenced the current price, it will certainly be a temporary divergence so I'll add "You're welcome and best of luck to you"
If, however it is the facts that have come to light and the actual performance metrics of ACGX and its management that have caused the slump in price, it may not be temporary. In fact, it may portend worse things to come.
The past, present, and future of ACGX lies in the hands of a small few people who live in or near CHICAGO. Unlike most publicly traded companies, the shareholders don't get a vote in anything. Even unwelcome questions on conference calls are stifled. Now those questions must be submitted and they pick and choose the one's they want to answer...
If, however it is the facts that have come to light and the actual performance metrics of DDI and its management that have caused the slump in price, it may not be temporary. In fact, it may portend worse things to come.
73 Ford Pinto.. Runs good and strong,, No rust ever,,
289 Engine
Hooker taped headers
C-4 rebuilt Transmission ($900.00)
9 inch Ford rear,, 2.5 Gears,, 4.11 Spare Avil...
Mustang 2 front end
Fiberglass hood
ACGX.. $0.0012.. From the ACGX website.. Today the number if you figured it out the ame as this PR inspired piece would be over 5 billion..
Alliance Creative Group Above Its SqueezeTrigger Price According to BUYINS.NET
Click Here for more Alliance Creative Group, Inc. (PC) Charts. Alliance Creative Group Above Its SqueezeTrigger Price According to BUYINS.NET
CHICAGO, IL--(Marketwired - June 05, 2014) -
•Approximately 1.53 Billion Total Shares Shorted Since November 2010
•Short Squeeze Has Begun As Stock Crosses Above $.00444 SqueezeTrigger Price
Alliance Creative Group (PINKSHEETS: ACGX) announces that BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has updated coverage on Alliance Creative Group after releasing the latest short sale data through June 4, 2014. The total aggregate number of shares shorted since November 2010 is approximately 1.53 billion shares. Approximately 40.43% of daily trading volume is short selling. The SqueezeTrigger price for all ACGX shares shorted is $.0044. A short squeeze is just starting as ACGX closed above its $.0033 SqueezeTrigger price.
Click for original Report: http://www.buyins.com/reports/acgx11-17-13.pdf
Click for updated SqueezeTrigger: http://www.buyins.com/images2/acgxstr6-4-14.jpg
Click for updated Friction Factor: http://www.buyins.com/images2/acgxff6-4-14.jpg
Click here for detailed explanation: http://www.buyins.com/brochure.pdf
Friction Factor calculates if a fair market is being made in the shares of ACGX. 39% of the previous 38 trading days have been positive or bullish-biased and 61% have been negative or bearish-biased.
Regulation SHO requires bona-fide market-making activities to include making purchases and sales in roughly comparable amounts. The Commission has stated that bona-fide market-making DOES NOT include activity that is related to speculative selling strategies or investment purposes of the broker-dealer and is disproportionate to the usual market making patterns or practices of the broker-dealer in that security. Likewise, where a market-maker posts continually at or near the best offer, but does not also post at or near the best bid, the market-maker's activities would not generally qualify as bona-fide market-making. Moreover, a market-maker that continually executes short sales away from its posted quotes would generally not be considered to be engaging in bona-fide market-making.
BUYINS.NET monitors ACGX market-makers daily for compliance with Fair Market-Making Requirements.
About Alliance Creative Group, Inc.
ALLIANCE CREATIVE GROUP, Inc. (PINKSHEETS: ACGX) is a printing, packaging, supply chain, product development and brand management marketing company. The Alliance Creative Group utilizes shared resources to create efficiencies between their projects and internal divisions to create quality results and long-term partnerships. The core business areas include creative and design services, printing and packaging, product fulfillment & logistics and strategic marketing. www.AllianceCreativeGroup.com and www.Print4aCause.com
About BUYINS.NET
BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies and comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor - market-maker surveillance system tracking market-makers to determine Price Friction and compliance with new "Fair Market-Making Requirements".
RegSHO Naked Shorts - tracks EVERY failure to deliver in all US stocks and all Threshold Security Lists daily for which stocks have naked short positions.
INVESTMENTS & TRADING
SqueezeTrigger - 40 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge - predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality - predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader - tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scanner - automates tracking of technical patterns and predicts next move in stocks.
GATS - tracks all strategies
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. Buyins.net has been paid $1,667 per month for data provided in six monthly reports. ACGX has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.
Contact:
BUYINS.NET
Thomas Ronk
800-715-9999
tom@buyins.net
http://www.buyins.net
KLYG..$0.073
Statement of Income
For the 2nd and 3rd Quarter Ended September 30, 2014
KELYNIAM GLOBAL, INC.
June 30, 2014,, September 30, 2014,, Year to Date
Sales $436,865 $455,401 $1,432,552
Cost of Sales 222,138 172,674 665,310
Gross Profit 214,727 282,727 767,242
General and administrative expenses 221,070 210,427 649,445
Income from Operations (6,343) 72,300 117,797
Other Income
Interest income 2 2 8
Net Income (6,341) 72,302 117,805
www.kelyniam.com
STOCKHOLDERS’ EQUITY
Common stock, $.001 par value, 60,000,000 shares authorized,
19,526,800 shares issued, 19,526,800 outstanding 19,017 19,017
Additional paid-in capital 2,436,564 2,436,564
Retained earnings (Deficit) (1,697,763) (1,654,001)
Total stockholders’ equity 757,818 801,580
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $1,444,223 $1,452,852
KLYG..$0.073
Statement of Income
For the 2nd and 3rd Quarter Ended September 30, 2014
KELYNIAM GLOBAL, INC.
June 30, 2014,, September 30, 2014,, Year to Date
Sales $436,865 $455,401 $1,432,552
Cost of Sales 222,138 172,674 665,310
Gross Profit 214,727 282,727 767,242
General and administrative expenses 221,070 210,427 649,445
Income from Operations (6,343) 72,300 117,797
Other Income
Interest income 2 2 8
Net Income (6,341) 72,302 117,805
www.kelyniam.com
STOCKHOLDERS’ EQUITY
Common stock, $.001 par value, 60,000,000 shares authorized,
19,526,800 shares issued, 19,526,800 outstanding 19,017 19,017
Additional paid-in capital 2,436,564 2,436,564
Retained earnings (Deficit) (1,697,763) (1,654,001)
Total stockholders’ equity 757,818 801,580
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $1,444,223 $1,452,852
KLYG $0.07.. Custom Cranial Implant Company Aims For Big Push In 2015
Posted in Implantable Devices by Arundhati Parmar on December 11, 2014
A Connecticut company wants to take more market share in the custom cranial and facial implant world.
The established names in the world of custom cranial and facial implants are the likes of Biomet, Stryker and Synthes.
However, there are small, boutique firms as well that compete with the big guys for the surgeon's mindshare. One such small manufacturer with roots in aerospace mechanical engineering and rapid prototyping wants to make a big play in 2015 by taking a large chunk of the revenue pie.
Kelyniam, based in Canton, Connecticut, believes it can do that because of a combination of rapid turnaround times and ease of implant placement. The company has been selling its custom implants made of polyether ether ketone (PEEK) OPTIMA, a colorless organic thermoplastic polymer that is transparent to X-rays, since January, 2012 after obtaining approval from the FDA in April, 2011.
That gap was meant to ensure that Kelyniam could create a scalable product development and manufacturing process, says Tennyson Anthony, president and CEO of the company in a recent phone interview.
“We are very confident that we can handle a significant volume without a hitch” or increase in turnaround times, Anthony declares.
Since 2012, roughly 400 procedures have involved Kelyniam’s implants. The company has market clearances in the U.S. and the Middle East, and the company is working to obtain regulatory clearances in Canada and Australia.
The goal is to have significant growth in 2015 and gain a foothold in the facial implant market as well, where most implants are typically off-the-shelf products.
So what is Kelyniam’s turnaround time?
From the time that the company receives a CT scan to when the implant is available for surgery can take as little as 24 hours.
Kelyniam executives underscore that the rapid turnaround time is a competitive advantage. Other implant makers take several days if not weeks to produce their implants.
“I think one of the most interesting things that I have learned in the short time that I have been here, is this less than 24-hour turnaround,” says John Mulvihill, vice president of sales, who joined Kelyniam in November as part of an acquisition. “That is unheard of not only in this market but in many others almost to the point that we have a number of our competition that calls us and orders the Kelyniam custom implant for their cases because their system hasn’t shown up yet.”
A plastic surgeon says it’s not that common for facial implants to be custom made. Usually off-the-shelf products work, but when they need to be custom made that takes some time.
“These custom implants generally require several weeks before being available. The facial plastic surgeon works with the company to create an appropriate implant,” says Houtan Chaboki, plastic surgeon, George Washington Medical Faculty Associates in Washington, D.C, in an email.
But cranial implants, sometimes can be made "on the spot" by head or neck surgeons, neurosurgeons or plastic surgeons using a“combination of titanium plates and/or hydroxyapetite or similar material,” he explains.
Kelyniam’s website offers three plans for custom cranial implants – an expedited plan whose turnaround time is 24 hours, a second plan by which the product is ready for the surgeon in 72 hours while a third plan makes the implant available in five or six days.
Another company – Kelyniam competitor Dallas-based MedCAD - that also makes implants using PEEK polymer can produce them in a few days.
“Is it humanly possible to create an implant within 24 hours? Yes, but it’s not necessary,” says Nancy Hairston, CEO of MedCAD.
She says that her company’s products are rarely used in emergency trauma scenarios because typically you have to wait for the swelling to go down.
“To be honest, if they need it in 24 hours that means somebody hasn’t been organized and they are rushing to bring the patient in,” Hairston declares.
For Kelyniam, the market is split 50-50 into trauma cases and implants required as a result of diseases such as tumor resections, Anthony explains.
“One of the things that we feel sets us apart from our competition is that we are having great success in working with the surgeons and designing an implant even before the resection so that it can be done in one surgery, where the surgeon goes in and takes the tumor out and then have the implant right there to put in,” he says.
One of the company’s products is an implant with tabs already in place.
“It’s an actual extension of the PEEK implant and surgeons don’t need to get a separate plate during surgery, so they can just place the implant on and use the screws that are available there,” explains Mulvihill. “So this really saves a lot of time and money.”
And that becomes important at a time when hospitals are making purchasing decisions with a laser-like focus on cost containment.
“We are very conscious of where the healthcare field is going and everybody is looking for better value,” Anthony says. “So we come in with these tabs and we eliminate the need for plating that can save them upwards of $2,000 for a particular procedure just in plates and screws.”
Kelyniam's outside spokesman noted that the 24-hour turnaround time also helps to free up hospital resources because it means patients are spending less time in the hospital waiting for the implant depending on the type of case.
Recently, the company helped create an implant for a U.S. patient that was particularly challenging. The patient had a gunshot wound, and from the CT scans, it was fairly obvious that there had been a previous surgery to secure broken bone, says Merwin Schaefer, Kelyniam’s chief design engineer.
“The part was created to mimic normal functioning of a healthy bone while reducing surgery and patient recovery times,” Schaefer says.
In fact, the final implant was a puzzle of four different pieces.
“The pieces were all slipped through a small incision and assembled once inside, which greatly reduced scarring and swelling and provided for a much better structural and aesthetic outcome,” Schaefer says.
Schaefer and company executives declined to say where the surgery was done because they are not at liberty to disclose details.
Already some physicians are noticing the Kelyniam difference, Tennyson says.
“We have had a doctor tell us that he truly believes that we saved a couple of his patients' lives because they came in and they were diagnosed with a tumor and they needed radiation treatment right away and because we were able to turn around the implant [quickly] that patient could receive the treatment within 48 hours,” he says.
Executives are hoping that such experiences will have a big impact on the company’s financial fortunes in 2015. The hope is also that a recent acquisition which brings the ability to bring to market neurostimulation products will boost financial results.
In the third quarter, Kelyniam had sales of $455,401 with a loss of $72,302. Kelyniam went public in 2008 and its stock is available over the counter.
Meanwhile, as it competes with companies like MedCAD, Kelyniam will also have to contend with the likes of Oxford Performance Materials, which has won FDA approval for its 3-D printed cranial and facial implants.
-- By Arundhati Parmar, Senior Editor, MD+DI
arundhati.parmar@ubm.com
KLYG $0.07.. Custom Cranial Implant Company Aims For Big Push In 2015
Posted in Implantable Devices by Arundhati Parmar on December 11, 2014
A Connecticut company wants to take more market share in the custom cranial and facial implant world.
The established names in the world of custom cranial and facial implants are the likes of Biomet, Stryker and Synthes.
However, there are small, boutique firms as well that compete with the big guys for the surgeon's mindshare. One such small manufacturer with roots in aerospace mechanical engineering and rapid prototyping wants to make a big play in 2015 by taking a large chunk of the revenue pie.
Kelyniam, based in Canton, Connecticut, believes it can do that because of a combination of rapid turnaround times and ease of implant placement. The company has been selling its custom implants made of polyether ether ketone (PEEK) OPTIMA, a colorless organic thermoplastic polymer that is transparent to X-rays, since January, 2012 after obtaining approval from the FDA in April, 2011.
That gap was meant to ensure that Kelyniam could create a scalable product development and manufacturing process, says Tennyson Anthony, president and CEO of the company in a recent phone interview.
“We are very confident that we can handle a significant volume without a hitch” or increase in turnaround times, Anthony declares.
Since 2012, roughly 400 procedures have involved Kelyniam’s implants. The company has market clearances in the U.S. and the Middle East, and the company is working to obtain regulatory clearances in Canada and Australia.
The goal is to have significant growth in 2015 and gain a foothold in the facial implant market as well, where most implants are typically off-the-shelf products.
So what is Kelyniam’s turnaround time?
From the time that the company receives a CT scan to when the implant is available for surgery can take as little as 24 hours.
Kelyniam executives underscore that the rapid turnaround time is a competitive advantage. Other implant makers take several days if not weeks to produce their implants.
“I think one of the most interesting things that I have learned in the short time that I have been here, is this less than 24-hour turnaround,” says John Mulvihill, vice president of sales, who joined Kelyniam in November as part of an acquisition. “That is unheard of not only in this market but in many others almost to the point that we have a number of our competition that calls us and orders the Kelyniam custom implant for their cases because their system hasn’t shown up yet.”
A plastic surgeon says it’s not that common for facial implants to be custom made. Usually off-the-shelf products work, but when they need to be custom made that takes some time.
“These custom implants generally require several weeks before being available. The facial plastic surgeon works with the company to create an appropriate implant,” says Houtan Chaboki, plastic surgeon, George Washington Medical Faculty Associates in Washington, D.C, in an email.
But cranial implants, sometimes can be made "on the spot" by head or neck surgeons, neurosurgeons or plastic surgeons using a“combination of titanium plates and/or hydroxyapetite or similar material,” he explains.
Kelyniam’s website offers three plans for custom cranial implants – an expedited plan whose turnaround time is 24 hours, a second plan by which the product is ready for the surgeon in 72 hours while a third plan makes the implant available in five or six days.
Another company – Kelyniam competitor Dallas-based MedCAD - that also makes implants using PEEK polymer can produce them in a few days.
“Is it humanly possible to create an implant within 24 hours? Yes, but it’s not necessary,” says Nancy Hairston, CEO of MedCAD.
She says that her company’s products are rarely used in emergency trauma scenarios because typically you have to wait for the swelling to go down.
“To be honest, if they need it in 24 hours that means somebody hasn’t been organized and they are rushing to bring the patient in,” Hairston declares.
For Kelyniam, the market is split 50-50 into trauma cases and implants required as a result of diseases such as tumor resections, Anthony explains.
“One of the things that we feel sets us apart from our competition is that we are having great success in working with the surgeons and designing an implant even before the resection so that it can be done in one surgery, where the surgeon goes in and takes the tumor out and then have the implant right there to put in,” he says.
One of the company’s products is an implant with tabs already in place.
“It’s an actual extension of the PEEK implant and surgeons don’t need to get a separate plate during surgery, so they can just place the implant on and use the screws that are available there,” explains Mulvihill. “So this really saves a lot of time and money.”
And that becomes important at a time when hospitals are making purchasing decisions with a laser-like focus on cost containment.
“We are very conscious of where the healthcare field is going and everybody is looking for better value,” Anthony says. “So we come in with these tabs and we eliminate the need for plating that can save them upwards of $2,000 for a particular procedure just in plates and screws.”
Kelyniam's outside spokesman noted that the 24-hour turnaround time also helps to free up hospital resources because it means patients are spending less time in the hospital waiting for the implant depending on the type of case.
Recently, the company helped create an implant for a U.S. patient that was particularly challenging. The patient had a gunshot wound, and from the CT scans, it was fairly obvious that there had been a previous surgery to secure broken bone, says Merwin Schaefer, Kelyniam’s chief design engineer.
“The part was created to mimic normal functioning of a healthy bone while reducing surgery and patient recovery times,” Schaefer says.
In fact, the final implant was a puzzle of four different pieces.
“The pieces were all slipped through a small incision and assembled once inside, which greatly reduced scarring and swelling and provided for a much better structural and aesthetic outcome,” Schaefer says.
Schaefer and company executives declined to say where the surgery was done because they are not at liberty to disclose details.
Already some physicians are noticing the Kelyniam difference, Tennyson says.
“We have had a doctor tell us that he truly believes that we saved a couple of his patients' lives because they came in and they were diagnosed with a tumor and they needed radiation treatment right away and because we were able to turn around the implant [quickly] that patient could receive the treatment within 48 hours,” he says.
Executives are hoping that such experiences will have a big impact on the company’s financial fortunes in 2015. The hope is also that a recent acquisition which brings the ability to bring to market neurostimulation products will boost financial results.
In the third quarter, Kelyniam had sales of $455,401 with a loss of $72,302. Kelyniam went public in 2008 and its stock is available over the counter.
Meanwhile, as it competes with companies like MedCAD, Kelyniam will also have to contend with the likes of Oxford Performance Materials, which has won FDA approval for its 3-D printed cranial and facial implants.
-- By Arundhati Parmar, Senior Editor, MD+DI
arundhati.parmar@ubm.com
KLYG $0.07.. Custom Cranial Implant Company Aims For Big Push In 2015
Posted in Implantable Devices by Arundhati Parmar on December 11, 2014
A Connecticut company wants to take more market share in the custom cranial and facial implant world.
The established names in the world of custom cranial and facial implants are the likes of Biomet, Stryker and Synthes.
However, there are small, boutique firms as well that compete with the big guys for the surgeon's mindshare. One such small manufacturer with roots in aerospace mechanical engineering and rapid prototyping wants to make a big play in 2015 by taking a large chunk of the revenue pie.
Kelyniam, based in Canton, Connecticut, believes it can do that because of a combination of rapid turnaround times and ease of implant placement. The company has been selling its custom implants made of polyether ether ketone (PEEK) OPTIMA, a colorless organic thermoplastic polymer that is transparent to X-rays, since January, 2012 after obtaining approval from the FDA in April, 2011.
That gap was meant to ensure that Kelyniam could create a scalable product development and manufacturing process, says Tennyson Anthony, president and CEO of the company in a recent phone interview.
“We are very confident that we can handle a significant volume without a hitch” or increase in turnaround times, Anthony declares.
Since 2012, roughly 400 procedures have involved Kelyniam’s implants. The company has market clearances in the U.S. and the Middle East, and the company is working to obtain regulatory clearances in Canada and Australia.
The goal is to have significant growth in 2015 and gain a foothold in the facial implant market as well, where most implants are typically off-the-shelf products.
So what is Kelyniam’s turnaround time?
From the time that the company receives a CT scan to when the implant is available for surgery can take as little as 24 hours.
Kelyniam executives underscore that the rapid turnaround time is a competitive advantage. Other implant makers take several days if not weeks to produce their implants.
“I think one of the most interesting things that I have learned in the short time that I have been here, is this less than 24-hour turnaround,” says John Mulvihill, vice president of sales, who joined Kelyniam in November as part of an acquisition. “That is unheard of not only in this market but in many others almost to the point that we have a number of our competition that calls us and orders the Kelyniam custom implant for their cases because their system hasn’t shown up yet.”
A plastic surgeon says it’s not that common for facial implants to be custom made. Usually off-the-shelf products work, but when they need to be custom made that takes some time.
“These custom implants generally require several weeks before being available. The facial plastic surgeon works with the company to create an appropriate implant,” says Houtan Chaboki, plastic surgeon, George Washington Medical Faculty Associates in Washington, D.C, in an email.
But cranial implants, sometimes can be made "on the spot" by head or neck surgeons, neurosurgeons or plastic surgeons using a“combination of titanium plates and/or hydroxyapetite or similar material,” he explains.
Kelyniam’s website offers three plans for custom cranial implants – an expedited plan whose turnaround time is 24 hours, a second plan by which the product is ready for the surgeon in 72 hours while a third plan makes the implant available in five or six days.
Another company – Kelyniam competitor Dallas-based MedCAD - that also makes implants using PEEK polymer can produce them in a few days.
“Is it humanly possible to create an implant within 24 hours? Yes, but it’s not necessary,” says Nancy Hairston, CEO of MedCAD.
She says that her company’s products are rarely used in emergency trauma scenarios because typically you have to wait for the swelling to go down.
“To be honest, if they need it in 24 hours that means somebody hasn’t been organized and they are rushing to bring the patient in,” Hairston declares.
For Kelyniam, the market is split 50-50 into trauma cases and implants required as a result of diseases such as tumor resections, Anthony explains.
“One of the things that we feel sets us apart from our competition is that we are having great success in working with the surgeons and designing an implant even before the resection so that it can be done in one surgery, where the surgeon goes in and takes the tumor out and then have the implant right there to put in,” he says.
One of the company’s products is an implant with tabs already in place.
“It’s an actual extension of the PEEK implant and surgeons don’t need to get a separate plate during surgery, so they can just place the implant on and use the screws that are available there,” explains Mulvihill. “So this really saves a lot of time and money.”
And that becomes important at a time when hospitals are making purchasing decisions with a laser-like focus on cost containment.
“We are very conscious of where the healthcare field is going and everybody is looking for better value,” Anthony says. “So we come in with these tabs and we eliminate the need for plating that can save them upwards of $2,000 for a particular procedure just in plates and screws.”
Kelyniam's outside spokesman noted that the 24-hour turnaround time also helps to free up hospital resources because it means patients are spending less time in the hospital waiting for the implant depending on the type of case.
custom cranial implant, skull implant, trauma
Digital Image of Four-Piece Implant
Recently, the company helped create an implant for a U.S. patient that was particularly challenging. The patient had a gunshot wound, and from the CT scans, it was fairly obvious that there had been a previous surgery to secure broken bone, says Merwin Schaefer, Kelyniam’s chief design engineer.
“The part was created to mimic normal functioning of a healthy bone while reducing surgery and patient recovery times,” Schaefer says.
In fact, the final implant was a puzzle of four different pieces.
“The pieces were all slipped through a small incision and assembled once inside, which greatly reduced scarring and swelling and provided for a much better structural and aesthetic outcome,” Schaefer says.
Schaefer and company executives declined to say where the surgery was done because they are not at liberty to disclose details.
Already some physicians are noticing the Kelyniam difference, Tennyson says.
“We have had a doctor tell us that he truly believes that we saved a couple of his patients' lives because they came in and they were diagnosed with a tumor and they needed radiation treatment right away and because we were able to turn around the implant [quickly] that patient could receive the treatment within 48 hours,” he says.
Executives are hoping that such experiences will have a big impact on the company’s financial fortunes in 2015. The hope is also that a recent acquisition which brings the ability to bring to market neurostimulation products will boost financial results.
In the third quarter, Kelyniam had sales of $455,401 with a loss of $72,302. Kelyniam went public in 2008 and its stock is available over the counter.
Meanwhile, as it competes with companies like MedCAD, Kelyniam will also have to contend with the likes of Oxford Performance Materials, which has won FDA approval for its 3-D printed cranial and facial implants.
-- By Arundhati Parmar, Senior Editor, MD+DI
arundhati.parmar@ubm.com
KLYG.. $0.07.. Worth a real look.. This is my stock for 2015..
KLYG certainly has a weird if not reclusive management style,, but that I can and have lived with.. The Med Ally Purchase/merger gave promise but still there has been no word from the company in over 6 month's.. They seem to act like a private company but in reality it's run by a bunch of nerds.. Their grasp of being public and the value of their stock just doesn't get thru to them.. back in the early 60's I worked at Brookhaven National Labs on Long Island NY just after getting out of the Navy on a graphite nuclear reactor ..
We had sci-guys from around the world coming their for their 15 Min of reactor time to do their research.. They would wait and watch others and even cook on sterno hot tops made out of coffee cans sometimes several months before their slot came up....
They would carry around open cokes in their lab coats and each time they bent over the coke would flow on their lab papers.. They had NO personality and were so engrossed in what they and others were doing they knew nothing about if it were night or day outside.. They were the pioneers of Nuclear Medicine..
This is what KLYG management is and has been before.. But now they have a real product that works and have been able to get the cost down recently 40%.. They have large companies looking and lurking at what they do and they have been able to grow sales over the years.. They as of their last filing have just become profitable..
But management doesn't have a clue as what it is to be public.. Stryker and others of the same size are lurking.. If you think it's frustrating,, try being their PR guy who they wouldn't even speak to,, who by the way is no longer on retainer..
if one were to go back into a few PR's and printed material on them they would get the feeling that this is a technology company on the move and will become a target of a buyout soon down the road.. that's the reason I'm still there and still swallow the Kool-Aid.. I believe that a buy-out bid this year of $0.50 is in the cards.. I will be in Ct. next month and I will make a visit to Canton,, their headquarters..
http://www.onlinetmd.com/tmd0315-Craniofacial-implants-technology.aspx#.VRb_QeFSVRk
http://www.hartfordbusiness.com/article/20150119/PRINTEDITION/301169938
http://www.kelyniam.com/news
KLYG.. $0.07.. Worth a real look.. This is my stock for 2015..
KLYG certainly has a weird if not reclusive management style,, but that I can and have lived with.. The Med Ally Purchase/merger gave promise but still there has been no word from the company in over 6 month's.. They seem to act like a private company but in reality it's run by a bunch of nerds.. Their grasp of being public and the value of their stock just doesn't get thru to them.. back in the early 60's I worked at Brookhaven National Labs on Long Island NY just after getting out of the Navy on a graphite nuclear reactor ..
We had sci-guys from around the world coming their for their 15 Min of reactor time to do their research.. They would wait and watch others and even cook on sterno hot tops made out of coffee cans sometimes several months before their slot came up....
They would carry around open cokes in their lab coats and each time they bent over the coke would flow on their lab papers.. They had NO personality and were so engrossed in what they and others were doing they knew nothing about if it were night or day outside.. They were the pioneers of Nuclear Medicine..
This is what KLYG management is and has been before.. But now they have a real product that works and have been able to get the cost down recently 40%.. They have large companies looking and lurking at what they do and they have been able to grow sales over the years.. They as of their last filing have just become profitable..
But management doesn't have a clue as what it is to be public.. Stryker and others of the same size are lurking.. If you think it's frustrating,, try being their PR guy who they wouldn't even speak to,, who by the way is no longer on retainer..
if one were to go back into a few PR's and printed material on them they would get the feeling that this is a technology company on the move and will become a target of a buyout soon down the road.. that's the reason I'm still there and still swallow the Kool-Aid.. I believe that a buy-out bid this year of $0.50 is in the cards.. I will be in Ct. next month and I will make a visit to Canton,, their headquarters..
http://www.onlinetmd.com/tmd0315-Craniofacial-implants-technology.aspx#.VRb_QeFSVRk
http://www.hartfordbusiness.com/article/20150119/PRINTEDITION/301169938
http://www.kelyniam.com/news
KLYG.. $0.07.. Worth a real look.. This is my stock for 2015..
KLYG certainly has a weird if not reclusive management style,, but that I can and have lived with.. The Med Ally Purchase/merger gave promise but still there has been no word from the company in over 6 month's.. They seem to act like a private company but in reality it's run by a bunch of nerds.. Their grasp of being public and the value of their stock just doesn't get thru to them.. back in the early 60's I worked at Brookhaven National Labs on Long Island NY just after getting out of the Navy on a graphite nuclear reactor ..
We had sci-guys from around the world coming their for their 15 Min of reactor time to do their research.. They would wait and watch others and even cook on sterno hot tops made out of coffee cans sometimes several months before their slot came up....
They would carry around open cokes in their lab coats and each time they bent over the coke would flow on their lab papers.. They had NO personality and were so engrossed in what they and others were doing they knew nothing about if it were night or day outside.. They were the pioneers of Nuclear Medicine..
This is what KLYG management is and has been before.. But now they have a real product that works and have been able to get the cost down recently 40%.. They have large companies looking and lurking at what they do and they have been able to grow sales over the years.. They as of their last filing have just become profitable..
But management doesn't have a clue as what it is to be public.. Stryker and others of the same size are lurking.. If you think it's frustrating,, try being their PR guy who they wouldn't even speak to,, who by the way is no longer on retainer..
if one were to go back into a few PR's and printed material on them they would get the feeling that this is a technology company on the move and will become a target of a buyout soon down the road.. that's the reason I'm still there and still swallow the Kool-Aid.. I believe that a buy-out bid this year of $0.50 is in the cards.. I will be in Ct. next month and I will make a visit to Canton,, their headquarters..
http://www.onlinetmd.com/tmd0315-Craniofacial-implants-technology.aspx#.VRb_QeFSVRk
http://www.hartfordbusiness.com/article/20150119/PRINTEDITION/301169938
http://www.kelyniam.com/news
ACGX.. $0.0012 Wow.. I Go out of Reception range W/O any internet and the first thing I see when I get back is this Chart (as I saw it quickly,, ACGX trades $0.05..???)..
Like I posted when I resigned being a mod was ACGX was a JOKE and it was trading @ $0.0024 then.. That was 3 trading day's ago..
Since it was all but admitted on the conference call there is a change in the Auth coming soon.. Check out when the Preferred issued last year when it may be converted and who it was sold to.. That may give some a clue as to why the stock is down so sharply.. Why should anyone convert when they can covert lower at a 30% discount much lower.. The lower it trades the more shares they get..
The selling is coming from where..???
ACGX.. $0.0018.. Looking back just a few Qtr's ago.. They have come a long way ... But within 3 months of this glowing release they increased shares by 50% to 12.3 Million and now soon we will see the 750 Million mark being passed.. 89 times the shares in this report.. hank
CHICAGO, Aug. 16, 2012 /PRNewswire/ -- Alliance Creative Group, Inc., (http://www.AllianceCreativeGroup.com) (Stock Symbol: ACGX) is pleased to announce the results of Operations for the Three Months Ended June 30, 2012 compared to the Three Months Ended June 30, 2011.
Revenues for the three months ended June 30, 2012 ("Second Quarter 2012") were $2,828,474 compared with $2,537,895 for the three months ended June 30, 2011 ("Second Quarter 2011"). That is an increase of $290,579 or 12% for the quarter.
Gross Profits for the three months ended June 30, 2012 ("Second Quarter 2012") were $774,727 compared with $596,553 for the three months ended June 30, 2011 ("Second Quarter 2011"). That is an increase of $178,174 or 30% for the quarter.
Net Income for the three months ended June 30, 2012 ("Second Quarter 2012") were $209,282 compared with $213,530 for the three months ended June 30, 2011 ("Second Quarter 2011"). That is a decrease of $4,248 or 2% decrease for the quarter due to some 1 time expenses and bad debt write off.
The total assets of the Alliance Creative Group as of 6/30/12 were $5,140,966. The total equity was $1,864,933. The total outstanding shares as of June 30, 2012 were 8,554,746 with 8,415,221 of those shares in the float. The stock is currently trading around the 2.5 cents per share range and the overall company market cap is around only $200,000.
The full financial statement, balance sheet, cash flow statement, stockholder equity and information and disclosure statements are on the Company website at http://alliancecreativegroup.com/investor-relations under the section for financials and on www.OTCmarkets.com under stock symbol ACGX.
CEO of the Alliance Creative Group, Steven St. Louis, said "I am very proud of our team and the progress we are making. This is our 11th consecutive quarter with over a million dollars in revenue and our earnings per share for 2012 are estimated to be around 12 cents a share. We moved into a larger office/warehouse location and have added some quality members to our growing team. We also purchased some additional equipment and are still evaluating other new technologies to help keep our competitive edge. Our Revenue and Gross Profits were both up but our Net Income was a little lower because of a few 1 time expenses and a bad debt write off. Now that we have moved into our new location we will be stepping up our efforts to find good strategic partners and potential acquisitions to help continue growing both organically and by acquisition. We will also continue to look for bigger and more long-term financial partners to help us get to the next level quicker. We feel our foundation is very solid and there are a lot of opportunities we want to evaluate. Our overall goals continue to be increased revenues, profits, stock price, stock liquidity and increased shareholder value and we will continue to look for and evaluate the best ways to accomplish these goals."
========================================
As per their press release..Shares Outstanding: The total outstanding shares as of November 13, 2012 are 12,349,477..
Float: 12,207,502
GATA.. $0.137.. Another 445,000 trades on the bid.. THINK WE SEE A POP SOON..???? HANK
GATA.. $0.137.. 350,000 just trade on the bid.. Nice.. hank